Value-Added Electrodiagnostics : Targeting Interventions for Fall Risk Reduction - 05/10/18
![](/templates/common/images/mail.png)
Résumé |
Walking confers numerous health benefits, particularly for middle-aged and older patients with diabetes and metabolic syndrome. Nevertheless, it brings a risk of injurious falls, especially among populations with diabetes and metabolic syndrome-related distal neuromuscular decline and frank neuropathy. Those who stand to benefit most from walking are at greatest risk. Development of practical clinical tools to more precisely quantify neuromuscular function and link it to mobility outcomes will help clinicians target interventions toward those at risk for falls. Electrodiagnosis, with inclusion of several newer techniques, serves as a promising tool for objective evaluation of distal neuromuscular function.
Le texte complet de cet article est disponible en PDF.Keywords : Neuropathy, Falls, Walking, Neuromuscular decline, Nerve conduction studies, Electromyography, Medial plantar, Electrodiagnosis
Plan
Disclosure Statement: No disclosures (S.L. Hearn). This work was supported by the National Institutes of Health ROI 5R01 AG026569 (J.K. Richardson). |
Vol 29 - N° 4
P. 645-657 - novembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?